Related Experiment Video
Updated: Aug 22, 2025

A TNBS-Induced Rodent Model to Study the Pathogenic Role of Mechanical Stress in Crohn's Disease
Published on: March 1, 2022
Hidradenitis suppurativa and inflammatory bowel disease in a nested case-control study
Benedetto Neri1, Michelangela Mossa1, Silvia Salvatori1
1Department of Systems Medicine, Gastroenterology Unit, University 'Tor Vergata' of Rome, Italy.
Patients with Inflammatory Bowel Disease (IBD) and Hidradenitis Suppurativa (HS) showed distinct clinical characteristics compared to those with HS alone. This suggests a need for careful skin assessment in IBD patients.
Area of Science:
- Dermatology
- Gastroenterology
- Clinical Research
Background:
- The association between Hidradenitis Suppurativa (HS) and Inflammatory Bowel Disease (IBD) is increasingly recognized.
- Understanding the distinct clinical profiles of patients with concomitant HS and IBD is crucial for effective management.
Purpose of the Study:
- To compare the clinical characteristics of Hidradenitis Suppurativa (HS) in patients with and without concomitant Inflammatory Bowel Disease (IBD).
- To identify potential differences in HS severity and treatment response between these patient groups.
Main Methods:
- A prospective, nested case-control study was conducted, matching IBD patients with HS (Cases) to HS patients without IBD (Controls).
- HS severity was assessed using the Hurley score and International HS Severity Score System (IHS4).
- Statistical analyses included t-tests, Mann-Whitney, chi-squared tests, and logistic regression.
Main Results:
- Obesity, familial HS, and perianal HS were less frequent in the IBD group compared to controls.
- HS severity, measured by IHS4, was significantly lower in patients with IBD.
- Complete drug-induced response for HS was more frequent in patients with IBD.
Conclusions:
- Significant differences exist in the clinical presentation and characteristics of HS between patients with and without IBD.
- These findings underscore the importance of vigilant dermatological assessment for HS in individuals diagnosed with IBD.
Related Concept Videos
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Inflammatory Bowel Disease V: Surgical Management
Here are some common surgical interventions for IBD:
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF

